(MENAFN- GlobeNewsWire - Nasdaq) The global tick-borne encephalitis (TBE) market is expanding rapidly, driven by the increasing prevalence of tick-borne diseases and growing awareness about TBE. This viral infection, transmitted by ticks, poses significant public health risks, particularly for outdoor workers, travelers, and underserved regions. The market's growth is bolstered by advancements in diagnostics and vaccines such as FSME-Immun and TBEV, and rising demand due to climate change-induced tick spread. Enhanced healthcare infrastructure, government vaccination initiatives, and digital health technologies like telemedicine are improving TBE management. Despite challenges like vaccine costs and uneven access, the market is sustained by strategic collaborations and innovation in vaccines and diagnostic tools.

Dublin, Oct. 06, 2025 (GLOBE NEWSWIRE) -- The "Tick Borne Encephalitis Market - A Global and Regional Analysis: Focus on Virus Type, End User, and Region - Analysis and Forecast, 2025-2035" report has been added to ResearchAndMarkets's offering.
The global tick-borne encephalitis (TBE) market is experiencing significant growth, driven by the increasing prevalence of tick-borne diseases, rising awareness of TBE, and advancements in diagnostic and vaccination options. TBE, a viral infection transmitted through the bite of infected ticks, remains a major public health concern, especially in regions with high-risk populations such as outdoor workers, travellers to endemic areas, and individuals in underserved regions.

As the geographic spread of ticks continues due to climate change, the demand for effective prevention, vaccination, and treatment options is expected to grow. This rise in TBE cases, coupled with the growing recognition of the disease's severity and its impact on public health, is driving market expansion.
Growth in the global TBE market is further supported by the increasing focus on early diagnosis, timely vaccination, and prevention strategies. Key preventive approaches include the use of vaccines such as FSME-Immun and TBEV, which remain critical for protection against TBE in endemic areas. Additionally, advancements in rapid diagnostic tests (RDTs) and molecular diagnostics are enabling early detection of TBE, improving patient outcomes, and reducing transmission. These innovations in diagnostic technology are helping healthcare providers better manage TBE cases, particularly in newly affected areas.
Improved healthcare infrastructure, particularly in emerging markets, is playing a crucial role in enhancing access to TBE vaccines, diagnostic tools, and treatment options. Governments and public health organizations are focusing on vaccine distribution and education campaigns to curb the spread of TBE, especially in regions with increasing tick populations due to climate change. Public health initiatives are also working to reduce the stigma around tick-borne diseases, promoting awareness of preventive measures and encouraging more people to seek vaccination and timely treatment.
Advancements in digital health technologies, such as telemedicine for remote consultations and mobile health applications for monitoring vaccination schedules, are expected to improve accessibility and patient engagement in TBE prevention and management. The development of self-testing kits and mobile platforms for tick-borne diseases may provide convenience and promote greater participation in early detection, particularly in rural or hard-to-reach areas with limited healthcare access.
Despite promising growth prospects, the TBE market faces challenges, including the high cost of vaccines and diagnostic technologies, limited access to healthcare in rural and low-resource settings, and inconsistent vaccine coverage across regions. Additionally, the geographical variability of tick populations and fluctuating rates of infection can lead to uneven demand for TBE-related products. Regulatory hurdles and lengthy approval processes for new vaccines and diagnostic tools may also delay the availability of innovative solutions, limiting the market's potential. Furthermore, there may be barriers related to public knowledge and acceptance of vaccination, particularly in regions where the risk of infection is perceived as low.
The competitive landscape of the TBE market is characterized by the involvement of leading pharmaceutical companies, vaccine manufacturers, and diagnostics firms. Strategic partnerships, collaborations, and mergers and acquisitions are common as stakeholders work to expand their product portfolios, enter new markets, and accelerate the development of more effective vaccines and diagnostic tools. Investments in research and development, particularly in the areas of next-generation vaccines and diagnostic platforms, are expected to drive market innovation and improve global health outcomes.
Looking ahead, the global TBE market is positioned for continued growth, driven by the increasing incidence of TBE, advancements in vaccine and diagnostic technologies, and a growing emphasis on public health initiatives, disease prevention, and patient education. The integration of digital health solutions, expanded vaccination programs, and ongoing innovations in vaccine research are expected to play key roles in improving patient management and reducing the global burden of TBE.

With continued investment in research, improved healthcare access, and effective prevention strategies, the TBE market is well-positioned to address the rising demand for management and treatment of this tick-borne disease worldwide.
Key Topics Covered:
1. Global Tick Borne Encephalitis Market: Industry Analysis
1.1 Market Overview and Ecosystem
1.2 Epidemiological Analysis
1.3 Key Market Trends
1.4 Regulatory Landscape
1.5 Pipeline Analysis
1.6 Market Dynamics
2. Global Tick Borne Encephalitis Market (by Virus Type)
2.1 European TBE Virus
2.2 Far Eastern TBE Virus
2.3 Siberian TBE Virus
3. Global Tick Borne Encephalitis Market (by End User)
3.1 Adult Vaccines
3.2 Pediatric Vaccines
3.3 Traveler Vaccines
4. Global Tick Borne Encephalitis Market (by Region)
4.1 North America
4.2 Europe
4.3 Asia-Pacific
4.4 Rest-of-the-World
5. Competitive Landscape and Company Profiles
5.1 Competitive Landscape
5.1.1 Mergers and Acquisitions
5.1.2 Partnership, Alliances and Business Expansion
5.1.3 New Offerings
5.1.4 Regulatory Activities
5.1.5 Funding Activities
5.2 Company Profiles

• Bavarian Nordic
• Baxter
• GSK plc.
• Merck & Co., Inc.
• Pfizer Inc.
• Sanofi
• Sonic HealthPlus
• Superdrug Health Clinic
• Valneva SE

For more information about this report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: Laura Wood,Senior Press Manager ... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN06102025004107003653ID1110154948